To hear about similar clinical trials, please enter your email below

Trial Title: Rehabilitation on Equal Terms - The ReMig Study

NCT ID: NCT05689398

Condition: Breast Cancer
Breast Neoplasms

Conditions: Official terms:
Breast Neoplasms

Conditions: Keywords:
Rehabilitation

Study type: Observational

Overall status: Recruiting

Study design:

Time perspective: Prospective

Summary: The ReMig-study aims to increase knowledge about rehabilitation needs, the rehabilitation process of arabic-speaking migrated women with BC, to increase the prerequisites for optimized and equal cancer care. The study aims to map migrated Arabic-speaking women's breast cancer rehabilitation with a focus on mental and physical recovery, lifestyle habits as well as satisfaction and goals with the rehabilitation and compare these outcomes with the outcomes of Swedish-speaking women. Further aim is to explore migrated Arabic-speaking women´s experiences and attitudes towards breast cancer rehabilitation.

Detailed description: Annually, over 2 million women are diagnosed with breast cancer (BC) globally, of which about 8300 in Sweden. Today, 20% of the Swedish population is foreign born and previous research has shown that women who have migrated are particularly vulnerable when diagnosed with BC. Research focusing on migrated women is sparse as they are often excluded from research, but available research shows that experience and management of BC differs depending on ethnicity, that the women to a lesser extent participate in BC screening and rehabilitation and that they have a higher mortality than Swedish born women. In recent years, measures to promote early BC diagnosis have been initiated, but knowledge of how optimized rehabilitation should be ensured to promote recovery and reduce the socioeconomic burden is lacking. This study aims to map the rehabilitation of migrant Arabic-speaking women with a focus on mental and physical recovery, lifestyle habits and satisfaction and goals with the rehabilitation in the first year after BC diagnosis and compare these outcomes with Swedish-speaking women. Further to elucidate migrated Arabic-speaking women´s experiences and attitudes towards breast cancer rehabilitation.

Criteria for eligibility:

Study pop:
Participants are planned to be recruited at breast cancer clinics in southern Sweden. The selection is coming to consist of Arabic-speaking women, ≤18 years of age who have migrated to Sweden and who have been diagnosed with BC (N=140). To this data comes a matched sample with data for Swedish-speaking women from the ReScreen study (dnr 201/505) to be used as a basis for the comparative analyses.

Sampling method: Probability Sample
Criteria:
Inclusion Criteria: - Undergone treatment for primary breast cancer - ≤18 years old - Ability to communicate in the Arabic language - Written informed consent Exclusion Criteria: - Recurrent disease - Palliative diagnosis - Pregnancy - Prior history of breast cancer - Inability to participate in the study due to cognitive impairment

Gender: Female

Minimum age: 18 Years

Maximum age: N/A

Healthy volunteers: No

Locations:

Facility:
Name: Lund University, Skåne university hospital, Helsingborgs sjukhus

Address:
City: Lund
Zip: 221 00
Country: Sweden

Status: Recruiting

Contact:
Last name: Marlene Malmström, Phd

Phone: +4646175950
Email: marlene.malmstrom@skane.se

Investigator:
Last name: Annette EW Holst-Hansson, PhD
Email: Principal Investigator

Start date: May 24, 2023

Completion date: May 15, 2025

Lead sponsor:
Agency: Lund University
Agency class: Other

Source: Lund University

Record processing date: ClinicalTrials.gov processed this data on November 12, 2024

Source: ClinicalTrials.gov page: https://clinicaltrials.gov/ct2/show/NCT05689398

Login to your account

Did you forget your password?